Aarti Drugs share news, announcements and annual reports
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹453.80up ₹18.60 (4.27%)BSE ₹453.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹435.20.
2 Nov: open ₹445.00, high ₹463.50, low ₹441.95
52-week range of traded prices to 2 Nov 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹4,142 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 21.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.67
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.44%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,50,10732.6% delivered
Aarti Drugs share news and announcements
832 announcements, routine notices left out, newest first. Page 12 of 17.
Dec 2015
Nov 2015
6 Nov · Updates
Oct 2015
Aug 2015
21 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2015
May 2015
Apr 2015
Mar 2015
24 Mar · Updates
17 Mar · Board meeting
To consider and approve the allotment of 121,08,550 Equity shares as Bonus issue in the proportion of 1 (One) new equity share for every 1 (One) existing fully paid equity shares as approved by the shareholders through postal ballot on March 13, 2015.13 Mar · Corporate action
Company has fixed Record Date as March 25, 2015 for the purpose of Allotment of Bonus shares.13 Mar · Disclosure of Voting Pattern - Clause 35A
Feb 2015
Jan 2015
30 Jan · Board meeting
Board of Directors of the Company at its meeting held on January 30, 2015, has inter alia approved the following subject to necessary approvals of Company's shareholders which would be obtained through Postal Ballot & E-Voting: 1. Increase of Authorized Share Capital & consequent alteration of Memorandum of Association: Authorized Share Capital of the Company will be increased from Rs. 21,50,00,000 to Rs. 25,00,00,000 and consequent alteration of Clause V of Memorandum of Association of the Company.30 Jan · Corporate action
Board of Directors have announced bonus equity shares by capitalization of reserves and surplus including securities premium account to existing shareholders of the Company in proportion of 1:1 i.e One equity share of Rs. 10 each fully paid for every existing one existing equity share of Rs. 10 each fully paid up held in the Company on the Record Date to be fixed in this behalf in due course.30 Jan · Dividend
Board of Directors of the Company at its meeting held on January 30, 2015 has declared 2nd interim dividend @ Rs. 5.00 ps per share for the financial year 2014-15.19 Jan · Dividend
Company will dispatch dividend warrants on February 10, 2015.19 Jan · Corporate action
Company has fixed Record Date as February 5, 2015 for the purpose of 2nd Interim Dividend.19 Jan · Board meeting
Inter-alia to : (1) Consider, approve and take on record audited financial results and accounts for the quarter and nine month ended on December 31, 2014. (2) Consider declaration of 2nd Interim Dividend, if any.
Dec 2014
Nov 2014
14 Nov · Dividend
Board of Directors of the Company at its meeting held on November 14, 2014 has declared Interim Dividend @ Rs. 5.00 ps (50%)per share for the financial year 2014-2015.3 Nov · Dividend
In case of approval of Interim Dividend by the Board of Directors, the Company will dispatch dividend warrants on November 27, 2014.3 Nov · Corporate action
Company has fixed Record Date as November 20, 2014 for the purpose of Payment of Interim Dividend, if any, declared.3 Nov · Board meeting
Inter-alia to: 1. Consider, approve and take on record audited financial results and accounts for the quarter and half year ended on September 30, 2014. 2. Consider declaration of Interim dividend, if any.
Oct 2014
Sep 2014
26 Sep · Management
Following changes have been effected /approved at the meeting of the Board of Directors held on September 26, 2014: 1. CA Priti P. Savla, has been appointed as an Independent and Women Director of the Company to fill the casual vacancy caused by resignation of CS Sunil M. Dedhia on April 01, 2014. 2. Shri Rashesh C. Gogri, Whole-time Direclor has been appointed and re-designated as the Managing Director of the Company.26 Sep · Management
Following changes have been effected /approved at the meeting of the Board of Directors held on September 26, 2014: